Antileukotriene therapy. Future directions (Q33836782)

29 July 2017

1 reference

title

Antileukotriene therapy. Future directions (English)

1 reference

29 July 2017

Holgate ST

1 reference

29 July 2017

Sampson AP

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

161

1 reference

29 July 2017

issue

2 Pt 2

1 reference

29 July 2017

page(s)

S147-53

1 reference

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

PAF and asthma--time for an appraisal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Cysteinyl leukotrienes in asthma: old mediators up to new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Residential Dampness Problems and Symptoms and Signs of Bronchial Obstruction in Young Norwegian Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Effects of leukotriene C4 and D4, histamine and bradykinin on cytosolic calcium concentrations and adhesiveness of endothelial cells and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Comparison of human eosinophil and neutrophil ligands for P-selectin: ligands for P-selectin differ from those for E-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Leukotriene receptors on human pulmonary vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Association of cigarette smoking and asbestos exposure with location and histology of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Characterization of the human 5-lipoxygenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Characterization of the human 5-lipoxygenase gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.SUPPLEMENT_1.LTTA-29

10.1164/AJRCCM.161.SUPPLEMENT_1.LTTA-29

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference